Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents

House Dust Mite Allergic Rhinitis Clinical Trial

Official title: Investigation of the Safety and Tolerability of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents With House Dust Mite-associated Allergic Rhinitis

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the safety and tolerability of different doses of sublingual tablets of house dust mite (HDM) allergen extracts in adolescents with house dust mite-associated allergic rhinitis.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• House Dust Mite Allergic Rhinitis
• Rhinitis

• NCT number: NCT01919554
• Study type: Interventional
• Source: Stallergenes
• Status: Completed
• Phase: Phase 1
• Start date: July 2013
• Completion date: September 2013